GYRE

Gyre Therapeutics Inc. Common Stock (GYRE)

Stock · NASDAQ · Health Care

$6.59as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Resistance level
$7.7
Industry
Biotechnology: Pharmaceutical Preparations

How Gyre Therapeutics Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$116.59MSG&A$85.98M (74%)R&D$13.70M (12%)Other$6.93M (6%)Cost of Revenue$5.42M (5%)Tax$4.56M (4%)GYRE

Source: 10-K filed Mar 13, 2026 · via SEC EDGAR / Finnhub

Gyre Therapeutics Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • GYRE
    Gyre Therapeutics Inc. Common Stock
    $6.59
    ▼ 1.35%
    Market cap $681.20MP/E
  • CLYM
    Climb Bio Inc. Common Stock
    $14.56
    ▼ 3.32%
    Market cap $676.28MP/E
    $1.54$18.33
  • OCS
    Oculis Holding AG Ordinary shares
    $12.21
    ▼ 1.77%
    Market cap $689.43MP/E
    $10.52$34.48
  • CTMX
    CytomX Therapeutics Inc. Common Stock
    $3.22
    ▼ 5.99%
    Market cap $690.12MP/E
    $1.9$8.21
  • BBOT
    BridgeBio Oncology Therapeutics Inc. Common Stock
    $8.74
    ▼ 4.79%
    Market cap $660.88MP/E
    $7$14.87
  • DRUG
    Bright Minds Biosciences Inc. Common Stock
    $72.74
    ▼ 2.41%
    Market cap $723.93MP/E
    $53.99$170
  • MNPR
    Monopar Therapeutics Inc. Common Stock
    $112.17
    ▼ 1.55%
    Market cap $747.88MP/E
    $32.04$124.82

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
3.18M
Total value held
$22.16M
Institutional holders
52
Top holders this quarter
  • Unknown984.2K
  • Unknown758.6K
  • Unknown431.4K
  • Unknown216.3K
  • Unknown170.8K
  • Unknown165.2K
  • Unknown133.8K
  • Unknown73.1K
  • Unknown43.1K
  • Unknown25.3K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.